Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MEIZHONG XU")

Results 1 to 5 of 5

  • Page / 1
Export

Selection :

  • and

A Novel Kinase Inhibitor, INCB28060, Blocks c-MET-Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3XIANGDONG LIU; QIAN WANG; BOER, Jason et al.Clinical cancer research (Print). 2011, Vol 17, Num 22, pp 7127-7138, issn 1078-0432, 12 p.Article

Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibitionBURNS, David M; LI, Yun-Long; COVINGTON, Maryanne B et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 13, pp 3525-3530, issn 0960-894X, 6 p.Article

Design and identification of selective HER-2 sheddase inhibitors via P1' manipulation and unconventional P2' perturbations to induce a molecular metamorphosisWENQING YAO; JINCONG ZHUO; MARANDO, Cindy A et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 1, pp 159-163, issn 0960-894X, 5 p.Article

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancerWENQING YAO; JINCONG ZHUO; QIYAN LIN et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 4, pp 603-606, issn 0022-2623, 4 p.Article

Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H, 5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-α antagonistsVOSS, Matthew E; CARTER, Percy H; STRZEMIENSKI, Paul et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 3, pp 533-538, issn 0960-894X, 6 p.Article

  • Page / 1